ClinicalTrials.gg
Drug

Revefenacin clinical trials

Also written TD-4208 and Yupelri.

studies test it
21
open now
2
in phase 3
6
first study started
2007

How each study uses revefenacin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the revefenacin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
9 Nov 2018 · YUPELRI · NDA 210598 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

revefenacin
15

Brand

Yupelri
4

Development codes

TD-4208
12
GSK1160724
1

Studies by the year they started

21 studies that test it; most in 2015 (6)

Studies that test revefenacin, by start year
YearStudies
20071
20111
20121
20142
20156
20161
20171
20181
20202
20212
20221
20231
20261

By phase

A phase 1/2 study counts in both.

Phase 1
6
Phase 2
5
Phase 3
6
Phase 4
4

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 17 · Other 4

Mylan Inc. (13) · University of Tennessee Graduate School of Medicine (3) · Mylan Pharma UK Ltd. (2) · University of California, Los Angeles (1) · Theravance Biopharma (1) · GlaxoSmithKline (1)

Often tested with

Tested in the same studies.

Formoterol (1) · GSK573719 (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test revefenacin.

Studies

Open first, then newest update. How each study uses revefenacin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 21

See all 21 studies that test revefenacin →

Codes

What other systems call revefenacin · ClinicalTrials.gg INT006351

  • MeSH (NLM) C583570revefenacinOne source NLM
  • UNII (FDA) G2AE2VE07OREVEFENACINConfirmed FDA, NLM, Wikidata
  • RxNorm 2102775One source FDA
  • Wikidata Q27278649revefenacinConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C152200RevefenacinOne source FDA
  • DrugBank DB11855One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.